CN100420478C - A medicine for treating hyperosteogeny and preparation method thereof - Google Patents
A medicine for treating hyperosteogeny and preparation method thereof Download PDFInfo
- Publication number
- CN100420478C CN100420478C CNB2006100510211A CN200610051021A CN100420478C CN 100420478 C CN100420478 C CN 100420478C CN B2006100510211 A CNB2006100510211 A CN B2006100510211A CN 200610051021 A CN200610051021 A CN 200610051021A CN 100420478 C CN100420478 C CN 100420478C
- Authority
- CN
- China
- Prior art keywords
- shares
- radix
- parts
- medicine
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 32
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 3
- 229940079593 drug Drugs 0.000 claims description 9
- 241000903946 Clematidis Species 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 241000241550 Cyathula Species 0.000 claims description 2
- 229940126701 oral medication Drugs 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 14
- 239000002994 raw material Substances 0.000 abstract description 13
- 238000005516 engineering process Methods 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000218158 Clematis Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 235000015096 spirit Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 108010048734 sclerotin Proteins 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a medicine for treating hyperosteogeny and a preparation method thereof. The medicine is prepared from the raw materials of the following proportion by weight: 30 to 80 shares of clematis root, 40 to 80 shares of rhizoma drynariae, 10 to 50 shares of radices cyathulae, 10 to 50 shares of divaricate saposhnikovia root, 10 to 30 shares of licorice roots northwest origin, 10 to 40 shares of fortune eupatorium herb, 10 to 30 shares of hemlock parsley and 30 to 80 shares of angelica and can also comprise 40 to 100 shares of shorthorned epimedium herb, 10 to 50 shares of rhizoma sparganii and 10 to 50 shares of himalayan teasel root. All the raw materials are pulverized, soaked in the distilled spirits of 45 to 60 DEG, which are 2 to 3 times as many as the total raw materials, for 7 to 15 days and then filtered; the filtered solution is the active ingredient of the medicine. The present invention has the advantages of short course of treatment for hyperosteogeny, rapid effect, radical cure, easily got raw material, low cost, simple production technology and no toxic side effect.
Description
Technical field
The invention belongs to medical technical field, relate in particular to a kind of medicine that is used for the treatment of hyperosteogeny, also relate to its preparation method simultaneously.
Background technology
The hyperosteogeny that partes corporis humani's branch produces, be mainly reflected in the human body different parts, osseous tissue proliferative lesion in various degree, its factor that produces pathological changes had a delicate constitution after people in middle age, sclerotin variability or stand for a long time, walking or be held in certain attitude for a long time, myotasis or avulsion are hemorrhage, hematoma fleshization, cause this position bone calcium to change, cause the excretory function obstacle, produce hyperosteogeny.
The treatment hyperosteogeny mainly adopts physical therapy, ultraviolet therapy, massage and traction, acupuncture, western medicine, operative treatment, traditional Chinese medical herbal treatment etc. at present.Because this disease belongs to frequently-occurring disease, commonly encountered diseases, and Western medicine does not have more satisfactory Therapeutic Method, so domestic in recent years a large amount of this disease of utilization traditional Chinese medical herbal treatment, method is different, and is rich and varied, obtained remarkable progress.Therapy can be divided into two classes substantially: a class belongs to the internal treatment, decoction promptly for oral administration, pill, powder, medicated wine etc.; The another kind of external treatment that belongs to, i.e. methods such as patch, drinks liniment, fumigation and wash method, external application.No matter treatment by oral administration of medicines, external treatment all have certain curative effect, but it is slower to take effect, and needs the regular hour, and the shortcoming that is difficult to effect a radical cure.
Summary of the invention
A kind of short treating period that the objective of the invention is to overcome above-mentioned shortcoming and provide, instant effect can effect a radical cure, and raw material is easy to get, and is cheap, and production technology is simple, the medicine that is used for the treatment of hyperosteogeny that has no side effect.
Another object of the present invention also is to be provided for treating the process for preparing medicine of hyperosteogeny.
Technical scheme of the present invention, be the inventor according to Tujia's secret prescription handed down in the family from generation to generation, sum up clinical experience for many years, carry out that a large amount of repetition tests draws, each amounts of components all has better curative effect in the following weight parts scope:
The medicine that is used for the treatment of hyperosteogeny of the present invention, it is the medicament of being made by the raw material of following weight parts:
Radix Clematidis 30-80 part Rhizoma Drynariae 40-80 part Radix Cyathulae 10-50 Radix Saposhnikoviae 10-50 part
Radix Glycyrrhizae 10-30 part Herba Eupatorii 10-40 part Rhizoma Chuanxiong 10-30 part Radix Angelicae Sinensis 30-80 part.
The above-mentioned medicine that is used for the treatment of hyperosteogeny also comprises the raw material of following weight parts:
Herba Epimedii 40-100 part rhizoma sparganic 10-50 part Radix Dipsaci 10-50 part.
The above-mentioned medicine that is used for the treatment of hyperosteogeny, preferably each amounts of components weight portion is:
30 parts of 40 portions of Radix Cyathulaes of 40 parts of Rhizoma Drynariae of Radix Clematidis, 20 Radix Saposhnikoviaes
40 parts of 30 parts of Radix Angelicae Sinensis of 20 parts of Rhizoma Chuanxiongs of 10 portions of Herba Eupatoriis of Radix Glycyrrhizae
30 parts of 30 parts of Radix Dipsacis of 40 parts of rhizoma sparganic of Herba Epimedii.
The preparation method that is used for the treatment of the medicament active composition of hyperosteogeny of the present invention with all raw material pulverizing, adds raw material total amount 2-3 45 °-60 ° Chinese liquor doubly, soaks after 7-15 days, filters, and filtrate is the active ingredient of medicine.
No matter the present invention is compared with prior art treating rule, formulation composition, still is being to select the equal obvious characteristic of tool in the medication.The present invention adopts the wine extraction active component, makes each crude drug behind 45 °-60 ° soaking in Chinese liquor, has reached sterilization effect preferably; The effect of Chinese liquor relaxing muscles and tendons to promote blood circulation can be accelerated the very fast absorption of human body to medicine.This medicine is through clinical verification, to treating hyperosteogeny short treating period, instant effect, can effecting a radical cure.Its raw material is easy to get simultaneously, and cost is low, and production technology is simple, has no side effect.Sclerotin such as necrosis of bone speech pathological changes is all produced effect.
The specific embodiment
Below further set forth beneficial effect of the present invention by clinical observation on the therapeutic effect test.
1, case is selected
The hyperosteogeny patient who meets the Western medicine diagnose standard that this tests 100 examples all derives from clinic case.Age 35-70 year, male's 78 examples wherein, women's 22 examples, age 35-40 year 12 examples, age 40-70 year 88 examples.
2, Therapeutic Method
The medicated wine of oral embodiment 1, each 10-20g, every day 3 times; 7 days is a course of treatment, is total to the 2-3 course of treatment.
4, curative effect determinate standard
With the doing well,improving degree is curative effect determinate standard, is divided into recovery from illness, effective, invalid 3 kinds.
Recovery from illness: treatment back subjective symptoms disappears, and X-ray shows that hyperosteogeny all disappears.
Effectively: subjective symptoms partly disappears, and pain symptom obviously alleviates.
Invalid: subjective symptoms and Signs do not have obvious change.
5, observed result
Clinical cure 88 examples, effective 10 examples, invalid 2 examples, cure rate is 88%, total effective rate is 98%.Only have 2 examples invalid in the treatment, all cases all have no adverse reaction.
To clinical cure personnel random inspection 12 people, follow up a case by regular visits to and do not see recurrence in 5 years.
Embodiment 1:
Take by weighing following bulk drugs:
Radix Clematidis 40g Rhizoma Drynariae 40g Radix Cyathulae 20g Radix Saposhnikoviae 30g
Radix Glycyrrhizae 10g Herba Eupatorii 20g Rhizoma Chuanxiong 30g Radix Angelicae Sinensis 40g
Herba Epimedii 40g rhizoma sparganic 30g Radix Dipsaci 30g.
With all raw material pulverizing, add 45 °-60 ° the Chinese liquor of 660g, soak after 10 days, to filter, filtrate is medicated wine.
Embodiment 2:
Take by weighing following bulk drugs:
Radix Clematidis 30g Rhizoma Drynariae 40g Radix Cyathulae 10g Radix Saposhnikoviae 10g
Radix Glycyrrhizae 10g Herba Eupatorii 10g Rhizoma Chuanxiong 10g Radix Angelicae Sinensis 30g
Herba Epimedii 40g rhizoma sparganic 10g Radix Dipsaci 10g.
With all raw material pulverizing, add 45 °-60 ° the Chinese liquor of 630g, soak after 15 days, to filter, filtrate is the active ingredient of medicine.
Embodiment 3:
Take by weighing following bulk drugs:
Radix Clematidis 80g Rhizoma Drynariae 80g Radix Cyathulae 50g Radix Saposhnikoviae 50g
Radix Glycyrrhizae 30g Herba Eupatorii 40g Rhizoma Chuanxiong 30g Radix Angelicae Sinensis 80g
Herba Epimedii 100g rhizoma sparganic 50g Radix Dipsaci 50.
With all raw material pulverizing, add 45 °-60 ° the Chinese liquor of 1280g, soak after 7 days, to filter, filtrate is the active ingredient of medicine.
The above, it only is preferred embodiment of the present invention, be not that the present invention is done any pro forma restriction, any technical solution of the present invention content that do not break away from,, all still belong in the scope of technical solution of the present invention any simple modification, equivalent variations and modification that above embodiment did according to technical spirit of the present invention.
Claims (3)
1. oral drugs that are used for the treatment of hyperosteogeny is characterized in that it is made up of following raw medicaments in portion by weight:
Radix Clematidis 30-80 part Rhizoma Drynariae 40-80 part Radix Cyathulae 10-50 part Radix Saposhnikoviae 10-50 part
Radix Glycyrrhizae 10-30 part Herba Eupatorii 10-40 part Rhizoma Chuanxiong 10-30 part Radix Angelicae Sinensis 30-80 part
Herba Epimedii 40-100 part rhizoma sparganic 10-50 part Radix Dipsaci 10-50 part.
2. the oral drugs that are used for the treatment of hyperosteogeny as claimed in claim 1, crude drug consumption weight portion is:
30 parts of 20 parts of Radix Saposhnikoviaes of 40 portions of Radix Cyathulaes of 40 parts of Rhizoma Drynariae of Radix Clematidis
40 parts of 30 parts of Radix Angelicae Sinensis of 20 parts of Rhizoma Chuanxiongs of 10 portions of Herba Eupatoriis of Radix Glycyrrhizae
30 parts of 30 parts of Radix Dipsacis of 40 parts of rhizoma sparganic of Herba Epimedii.
3. the preparation method that is used for the treatment of the oral drugs of hyperosteogeny as claimed in claim 1 or 2, it is characterized in that described method for all crude drug are pulverized, add crude drug total amount 2-3 45 °-60 ° Chinese liquor doubly, soak after 7-15 days, filter, filtrate is the active ingredient of medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100510211A CN100420478C (en) | 2006-04-21 | 2006-04-21 | A medicine for treating hyperosteogeny and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100510211A CN100420478C (en) | 2006-04-21 | 2006-04-21 | A medicine for treating hyperosteogeny and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1876114A CN1876114A (en) | 2006-12-13 |
| CN100420478C true CN100420478C (en) | 2008-09-24 |
Family
ID=37508783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100510211A Expired - Fee Related CN100420478C (en) | 2006-04-21 | 2006-04-21 | A medicine for treating hyperosteogeny and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100420478C (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1413680A (en) * | 2002-10-21 | 2003-04-30 | 罗孝华 | Chinese medicine for treating hyperosteogeny |
| CN1465385A (en) * | 2002-06-21 | 2004-01-07 | 程光智 | Chinese medicine for treating lumbar vertebrae hyperosteogeny |
| CN1468608A (en) * | 2002-07-19 | 2004-01-21 | 张长春 | Chinese medicine for treating hyperosteogeny |
-
2006
- 2006-04-21 CN CNB2006100510211A patent/CN100420478C/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1465385A (en) * | 2002-06-21 | 2004-01-07 | 程光智 | Chinese medicine for treating lumbar vertebrae hyperosteogeny |
| CN1468608A (en) * | 2002-07-19 | 2004-01-21 | 张长春 | Chinese medicine for treating hyperosteogeny |
| CN1413680A (en) * | 2002-10-21 | 2003-04-30 | 罗孝华 | Chinese medicine for treating hyperosteogeny |
Non-Patent Citations (4)
| Title |
|---|
| 治疗骨质增生的体会. 何绍奇.中国临床医生，第31卷第12期. 2003 |
| 治疗骨质增生的体会. 何绍奇.中国临床医生，第31卷第12期. 2003 * |
| 骨质增生中医药治疗概况. 刘乡.甘肃中医学院学报，第11卷第4期. 1992 |
| 骨质增生中医药治疗概况. 刘乡.甘肃中医学院学报，第11卷第4期. 1992 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1876114A (en) | 2006-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101972453B (en) | Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof | |
| CN101810685B (en) | Chinese medicinal composition for treating gonitis and preparation method thereof | |
| CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
| CN101085327A (en) | Traditional Chinese medicine cutaneous permeable agent | |
| CN102119990A (en) | Chinese medicinal preparation for nourishing liver and kidney, supplementing qi, engendering blood, promoting blood circulation, removing obstruction in channels and relieving pain | |
| CN103263659A (en) | Traditional Chinese medicine composition for treating rheumatism bone diseases | |
| CN100372551C (en) | Chinese medicine for treating hyperosteogeny | |
| CN100420478C (en) | A medicine for treating hyperosteogeny and preparation method thereof | |
| CN103316228A (en) | Scorpio unsting wine | |
| CN102512645A (en) | Traditional Chinese medicine composition for treating lumbago due to cold dampness | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN101530522B (en) | Traditional Chinese medicine preparation for treating wind-cold-dampness pain | |
| CN105561184A (en) | Medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and preparation method thereof | |
| CN103070997A (en) | Drug for curing ischialgia and preparing method thereof | |
| CN103751467A (en) | Traditional Chinese medicine composition for treating lumbar and back myofascitis and preparation method thereof | |
| CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
| CN101904992B (en) | Chinese medicinal preparation for treating traumatic injury | |
| CN100384446C (en) | Medicine emplastrum for treating osteoproliferation and its preparing method | |
| CN102068534B (en) | Chinese medicinal composition for relaxing tendons and activating collaterals and preparation method thereof | |
| CN101862430B (en) | Chinese medicament for treating femoral head necrosis and preparation method thereof | |
| CN101843810A (en) | Medicinal liquor for treating bi syndromes and preparation method thereof | |
| CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
| CN105106786A (en) | Traditional Chinese medicine composition capable of dredging collaterals and relaxing muscles as well as preparation and production method of composition | |
| CN105664143A (en) | Medicinal composition with body building and yang strengthening functions and preparation method thereof | |
| CN114259551A (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080924 |